In vivo purging with Rituximab before autologous peripheral blood progenitor cell (PBPC) transplantation in lymphoma patients (PTS).

被引：0

作者：

Salles, G ^{[1
]}

Moullet, I ^{[1
]}

Charlot, C ^{[1
]}

Thieblemont, C ^{[1
]}

Bouafia, F ^{[1
]}

Dumontet, C ^{[1
]}

Espinouse, D ^{[1
]}

Coiffier, B ^{[1
]}

机构：

[1] Ctr Hosp Lyon Sud, Hematol Serv, F-69310 Pierre Benite, France

来源：

BLOOD | 1999年 / 94卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

619

引用

页码：141A / 141A

页数：1

共 50 条

[41] Peripheral blood progenitor cells (PBPC) mobilized at the time of haematopoietic reconstitution after autologous transplantation. [J].

Koza, V ;

Jindra, P ;

Lysák, D ;

Skopek, P ;

Cetkovsky, P .

BONE MARROW TRANSPLANTATION, 1999, 23 :S203-S203

[42] High efficacy and good tolerability with rituximab in vivo purging followed by high dose chemotheraphy and autologous peripheral blood stem cell transplantation (APBSCT) in non-Hodgkin's lymphoma (NHL). [J].

Shi, YK ;

Yang, S ;

Han, XH ;

Liu, P ;

He, XH ;

Ma, J ;

Ren, HY ;

Cen, X ;

Zhou, SY ;

Wang, C .

BLOOD, 2004, 104 (11) :240B-240B

[43] In vivo plus ex vivo purging during autologous peripheral blood stem cell transplantation in high-grade B cell non-Hodgkin's lymphoma [J].

Arpaci, F. ;

Erdem, G. ;

Ataergin, S. ;

Cetin, T. ;

Ozturk, M. ;

Kuzhan, O. ;

Komurcu, S. ;

Ozet, A. ;

Cayakar, A. ;

Eren, O. .

BONE MARROW TRANSPLANTATION, 2011, 46 :S346-S346

[44] EARLY HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATION IN PATIENTS WITH HIGH-RISK, AGGRESSIVE NON-HODGKINS-LYMPHOMA [J].

BRUGGER, W ;

GRAMATZKI, M ;

KOLLMANNSBERGER, C ;

KIEFER, T ;

MERTELSMANN, R ;

KANZ, L .

BLOOD, 1994, 84 (10) :A234-A234

[45] Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC) [J].

Bredeson, C ;

Malcolm, J ;

Davis, M ;

BenceBruckler, I ;

Kearns, B ;

Huebsch, L .

BONE MARROW TRANSPLANTATION, 1997, 20 (10) :889-896

[46] Outcome and factors associated with slow mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing autologous transplantation for non-Hodgkin's lymphoma (NHL). [J].

Bociek, RG ;

Lynch, JC ;

Yee, GC ;

Bierman, PJ ;

Vose, JM ;

Armitage, JO ;

Brannan, RL ;

Petersen, KA ;

Kessinger, A .

BLOOD, 2001, 98 (11) :861A-861A

[47] Salvage chemotherapy and autologous peripheral blood progenitor cells transplantation in resistant lymphoma [J].

Sica, S ;

Salutari, P ;

Chiusolo, P ;

DiMario, A ;

Teofili, L ;

Marra, R ;

Micciulli, G ;

LaBarbera, EO ;

Leone, G .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 :348-348

[48] Arterial blood oxygenation, maximum exercise capacity and oxygen transport in patients before and after autologous peripheral blood progenitor cell transplantation [J].

A Gruber ;

T Brundin ;

M Björkholm .

Bone Marrow Transplantation, 1999, 24 :169-172

[49] Arterial blood oxygenation, maximum exercise capacity and oxygen transport in patients before and after autologous peripheral blood progenitor cell transplantation [J].

Gruber, A ;

Brundin, T ;

Björkholm, M .

BONE MARROW TRANSPLANTATION, 1999, 24 (02) :169-172

[50] Favourable outcome of mantle cell lymphoma after autologous stem cell transplantation with in vivo or ex vivo purging [J].

Kuwatsuka, Y. ;

Kato, H. ;

Oki, Y. ;

Taji, H. ;

Yamamoto, K. ;

Kagami, Y. ;

Morishima, Y. .

BONE MARROW TRANSPLANTATION, 2008, 41 :S255-S256

← 1 2 3 4 5 →